In this webinar, the speakers will examine the results of a large genetic epilepsy study conducted using the Invitae Epilepsy Panel to test more than 9,700 individuals. They will reinforce the need for early detection with genetic testing, discuss the potential precision medicine implications for patients, and highlight the benefits of our sponsored testing program for pediatric epilepsy.
Estimate your out-of-pocket cost for Invitae tests related to a personal or family history of breast, ovarian, colorectal, or uterine cancer.
The amount shown above is an estimate of your out-of-pocket cost based upon the information you entered about your health insurance coverage. It is not a confirmation that the test has been authorized by your insurance provider. Your final cost may vary based upon your health plan design, deductible, co-insurance, and out-of-pocket limits. Learn More >
As part of Invitae’s dedication to making high-quality genetic testing affordable and accessible, we also offer a patient pre-pay option of $250. Learn More >
We could not determine an out-of-pocket estimate. Please contact us for assistance.